View in EDS

Clinical validation of a plasma-based antibody-free LC-MS method for identifying CSF amyloid positivity in mild cognitive impairment.

Saved in:
Bibliographic Details
Title: Clinical validation of a plasma-based antibody-free LC-MS method for identifying CSF amyloid positivity in mild cognitive impairment.
Authors: Allué JA; Araclon Biotech-Grifols, Zaragoza, Spain., Sarasa L; Araclon Biotech-Grifols, Zaragoza, Spain., Fandos N; Araclon Biotech-Grifols, Zaragoza, Spain., Gonzalo R; Scientific Innovation Office, Grifols S.A., Barcelona, Spain., Sabido-Vera R; Scientific Innovation Office, Grifols S.A., Barcelona, Spain., Loscos J; Araclon Biotech-Grifols, Zaragoza, Spain., Romero J; Araclon Biotech-Grifols, Zaragoza, Spain., Sánchez A; Araclon Biotech-Grifols, Zaragoza, Spain., Terencio J; Araclon Biotech-Grifols, Zaragoza, Spain.; Scientific Innovation Office, Grifols S.A., Barcelona, Spain., Matias-Guiu JA; Hospital Clínico Universitario San Carlos, Madrid, Spain., Piñol-Ripoll G; Unitat de Trastorns Cognitius, Hospital Universitari Santa Maria, Lleida, Spain.; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Fundació de Recerca Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Pascual-Lucas M; Araclon Biotech-Grifols, Zaragoza, Spain.
Source: Frontiers in aging neuroscience [Front Aging Neurosci] 2025 Oct 10; Vol. 17, pp. 1681516. Date of Electronic Publication: 2025 Oct 10 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101525824 Publication Model: eCollection Cited Medium: Print ISSN: 1663-4365 (Print) Linking ISSN: 16634365 NLM ISO Abbreviation: Front Aging Neurosci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1663-4365
DOI:10.3389/fnagi.2025.1681516